VERX logo

VERX
Vertex Inc - Ordinary Shares Class A

450
Mkt Cap
$1.98B
Volume
1.08M
52W High
$42.44
52W Low
$10.59
PE Ratio
303.92
VERX Fundamentals
Price
$13.19
Prev Close
$12.37
Open
$12.60
50D MA
$12.83
Beta
0.88
Avg. Volume
1.1M
EPS (Annual)
$0.0444
P/B
8.14
Rev/Employee
$356,401.91
$3,256.04
Loading...
Loading...
News
all
press releases
Biotech Stocks To Follow Today - May 1st
Moderna, Danaher, Lakewood-Amedex Biotherapeutics, Celcuity, and Vertex Pharmaceuticals are the five Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that use biological research and technologies to discover, develop, and commercia...
MarketBeat·11h ago
News Placeholder
More News
News Placeholder
Danske Bank A S Decreases Holdings in Vertex Pharmaceuticals Incorporated $VRTX
Danske Bank A S trimmed its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 4.4% in the fourth quarter, according to its most recent filing with the...
MarketBeat·19h ago
News Placeholder
Biotech Stocks To Follow Today - April 30th
Danaher, argenex, and Vertex Pharmaceuticals are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies whose primary business is developing or commercializing biological products and technologiessuch as drugs...
MarketBeat·2d ago
News Placeholder
Vertex Pharmaceuticals Incorporated $VRTX Stake Reduced by Jennison Associates LLC
Jennison Associates LLC reduced its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 5.9% in the fourth quarter, according to the company in its most recent 13F...
MarketBeat·2d ago
News Placeholder
Vertex, Inc. (NASDAQ:VERX) Given Consensus Rating of "Hold" by Brokerages
Shares of Vertex, Inc. (NASDAQ:VERX - Get Free Report) have been assigned an average recommendation of "Hold" from the thirteen research firms that are covering the firm, MarketBeat.com reports. One...
MarketBeat·2d ago
News Placeholder
Vertex (VERX) Projected to Post Quarterly Earnings on Thursday
Vertex (NASDAQ:VERX) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-vertex-inc-stock...
MarketBeat·2d ago
News Placeholder
Best Biotech Stocks To Watch Today - April 29th
Danaher, Oruka Therapeutics, and Vertex Pharmaceuticals are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies that apply biological research and technology to develop medicines, therapies, diagnostics, and...
MarketBeat·2d ago
News Placeholder
Wealthfront Advisers LLC Boosts Stake in Vertex Pharmaceuticals Incorporated $VRTX
Wealthfront Advisers LLC raised its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 15.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 43,169 share...
MarketBeat·3d ago
News Placeholder
FY2026 Earnings Forecast for VRTX Issued By Erste Group Bank
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) - Investment analysts at Erste Group Bank reduced their FY2026 earnings per share (EPS) estimates for shares of Vertex Pharmaceuticals...
MarketBeat·3d ago
News Placeholder
Best Biotech Stocks To Add to Your Watchlist - April 28th
Danaher, Medpace, Vertex Pharmaceuticals, Oruka Therapeutics, Amicus Therapeutics, argenex, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool...
MarketBeat·3d ago
<
1
2
...
>

Latest VERX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.